Voriconazole for Candidosis: An Important Addition?

Lancet. 2005 Oct 22-28;366(9495):1413-4. doi: 10.1016/S0140-6736(05)67579-4.

Publication types

  • Comment

MeSH terms

  • Amphotericin B / administration & dosage
  • Amphotericin B / adverse effects
  • Amphotericin B / therapeutic use*
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / adverse effects
  • Antifungal Agents / therapeutic use*
  • Candida albicans / drug effects
  • Candida glabrata / drug effects
  • Candidiasis / drug therapy*
  • Caspofungin
  • Drug Administration Schedule
  • Echinocandins
  • Fluconazole / administration & dosage
  • Fluconazole / therapeutic use*
  • Humans
  • Lipopeptides
  • Peptides, Cyclic / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Triazoles / therapeutic use*
  • Voriconazole

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Peptides, Cyclic
  • Pyrimidines
  • Triazoles
  • Amphotericin B
  • Fluconazole
  • Caspofungin
  • Voriconazole